A targeted phototheranostic agent with strong AIE effect and boosted type I ROS generation
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Design of superior phototheranostic agents guided by Jablonski diagrams10.1039/D0CS00671H ↗
2. Emerging nanotechnology and advanced materials for cancer radiation therapy10.1002/adma.201700996 ↗
3. Bioorthogonal coordination polymer nanoparticles with aggregation-induced emission for deep tumor-penetrating radio- and radiodynamic therapy
4. Enhanced type I photoreaction of indocyanine green via electrostatic- force-driven aggregation10.1039/D0NR01208D ↗
5. Regulation of antimicrobial effect of hemicyanine-based photosensitizer via supramole- cular assembly10.3390/nano12172905 ↗
6. In situ-induced multivalent anticancer drug clusters in cancer cells for enhancing drug efficacy10.31635/ccschem.019.20180015 ↗
7. Conjugated molecule-assisted supramolecular hydrogel with enhanced antibacterial and antibiofouling properties10.1021/acsabm.2c00385 ↗
8. Fusobacterium in colonic flora and molecular features of colorectal carcinoma10.1158/0008-5472.CAN-13-1865 ↗
9. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy10.1016/j.cell.2017.07.008 ↗
10. Analysis of fusobacterium persistence and antibiotic response in colorectal cancer10.1126/science.aal5240 ↗
11. Molecular engineering of high-performance aggregation-induced emission photosensitizers to boost cancer theranostics mediated by acid-triggered nucleus-targeted nanovectors10.1021/acsnano.1c03700 ↗
12. A feasible strategy of fabricating type I photosensitizer for photodynamic therapy in cancer cells and pathogens10.1021/acsnano.1c01577 ↗
13. Activatable polymer nanoenzymes for photodynamic immunometabolic cancer therapy10.1002/adma.202007247 ↗
14. Photoactivatable protherapeutic nanomedicine for cancer
15. Super-efficient in vivo two-photon photodynamic therapy with a gold nanocluster as a type I photosensitizer10.1021/acsnano.9b05169 ↗
16. Design and structural regulation of AIE photosensitizers for imaging-guided photodynamic anti-tumor application10.1039/D2BM00864E ↗
17. Acceptor planarization and donor rotation: a facile strategy for realizing synergistic cancer phototherapy via type I PDT and PTT10.1021/acsnano.1c10019 ↗
18. Type I macrophage activator photosensitizer against hypoxic tumors10.1039/D1SC04124J ↗
19. 9,10-Phenanthrenequinone: a promising kernel to develop multifunctional antitumor systems for efficient type I photodynamic and photothermal synergistic therapy10.1021/acsnano.1c07730 ↗
20. An NIR-II-emissive photosensitizer for hypoxia-tolerant photodynamic theranostics10.1002/adma.202003471 ↗
21. Type I photosensitizers based on phosphindole oxide for photodynamic therapy: apoptosis and autophagy induced by endoplasmic reticulum stress10.1039/D0SC00785D ↗
22. Enhancement of tumor lethality of ROS in photodynamic therapy10.1002/cam4.3592 ↗
23. A nanostructured phthalocyanine/albumin supramolecular assembly for fluorescence turn-on imaging and photodynamic immunotherapy10.1021/acsnano.1c10565 ↗
24. Single-crystal C60 needle/CuPc nanoparticle double floating-gate for low-voltage organic transistors based non-volatile memory devices10.1002/adma.201403771 ↗
25. O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia10.7150/thno.22465 ↗
26. Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses10.1038/s41467-017-01050-0 ↗
27. Near-infrared light-initiated molecular superoxide radical generator: rejuvenating photodynamic therapy against hypoxic tumors10.1021/jacs.8b08658 ↗
28. Phthalocyanine-assembled nanodots as photosensitizers for highly efficient type I photoreactions in photodynamic therapy10.1002/anie.201806551 ↗
29. A Bacteriochlorin-based metal-organic framework nanosheet superoxide radical generator for photoacoustic imaging-guided highly efficient photodynamic therapy
30. Titanium-based nanoscale metal-organic framework for type I photodynamic therapy10.1021/jacs.8b13804 ↗
31. Achieving efficient photodynamic therapy under both normoxia and hypoxia using cyclometalated Ru(ii) photosensitizer through type I photochemical process10.1039/C7SC03765A ↗
32. An emerging molecular design approach to heavy-atom-free photosensitizers for enhanced photodynamic therapy under hypoxia10.1021/jacs.9b09220 ↗
33. Phthalocyanine-assembled “one-for-two” nanoparticles for combined photodynamic-photothermal therapy of multidrug-resistant bacteria10.1021/acsami.1c21891 ↗
34. Good Steel Used in the Blade: well-tailored type-I photosensitizers with aggregation-induced emission characteristics for precise nuclear targeting photodynamic therapy10.1002/advs.202100524 ↗
35. Aggregation-induced emission of 1-methyl-1,2,3,4,5-pentaphenylsilole10.1039/b105159h ↗
36. Aggregation-enhanced theranostics: AIE sparkles in biomedical field10.1002/agt2.7 ↗
37. Recent advances in hypoxia-overcoming strategy of aggregation-induced emission photosensitizers for efficient photodynamic therapy10.1002/adhm.202101607 ↗
38. Precise molecular engineering of type I photosensitizers with near-infrared aggregation-induced emission for image-guided photodynamic killing of multidrug-resistant bacteria10.1002/advs.202104079 ↗
39. Bioactive AIEgens tailored for specific and sensitive theranostics of Gram-positive bacterial infection10.1021/acsami.2c14550 ↗
40. Molecular engineering of efficient singlet oxygen generators with near-infrared AIE features for mitochondrial targeted photodynamic therapy10.1002/adfm.202104026 ↗
41. Mitochondria-targeted smart AIEgens: imaging and therapeutics10.1016/j.ccr.2022.214818 ↗